TriSalus Life Sciences
TLSI
84 hedge funds and large institutions have $83.3M invested in TriSalus Life Sciences in 2026 Q1 according to their latest regulatory filings, with 29 funds opening new positions, 25 increasing their positions, 14 reducing their positions, and 10 closing their positions.
190% more first-time investments, than exits
New positions opened: 29 | Existing positions closed: 10
79% more repeat investments, than reductions
Existing positions increased: 25 | Existing positions reduced: 14
25% more funds holding
Funds holding: 67 → 84 (+17)
11.08% more ownership
Funds ownership: 22.88% → 33.96% (+11%)
4% more capital invested
Capital invested by funds: $79.8M → $83.3M (+$3.48M)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
FLAM
First Light Asset Management
Edina,
Minnesota
|
+$24.8M |
| 2 |
WA
Wasatch Advisors
Salt Lake City,
Utah
|
+$7.04M |
| 3 |
AIC
AWM Investment Company
New York
|
+$4.09M |
| 4 |
Cerity Partners
New York
|
+$3.85M |
| 5 |
TSW
Thompson Siegel & Walmsley
Richmond,
Virginia
|
+$2.86M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
WAP
Wealthcare Advisory Partners
West Chester,
Pennsylvania
|
-$4.49M |
| 2 |
Alyeska Investment Group
Chicago,
Illinois
|
-$2.84M |
| 3 |
GGHC
Gilder Gagnon Howe & Co
New York
|
-$443K |
| 4 |
Squarepoint
New York
|
-$310K |
| 5 |
Millennium Management
New York
|
-$249K |
TLSI Hedge Fund Activity: Q1 2026 in Review
84 of the 8,126 institutional investors tracked by Wall St. Rank reported a position in TriSalus Life Sciences (TLSI) for Q1 2026, worth a combined $83.3M — up 4.4% from $79.8M a quarter earlier.
Buyers outnumbered sellers: 29 funds opened new TLSI positions and 10 closed out — a net gain of 19 holders — while 25 added to existing stakes and 14 trimmed.
The largest buyer was First Light Asset Management, opening a new position worth an estimated $24.8M. The largest seller was Wealthcare Advisory Partners, exiting entirely with an estimated $4.49M sold.
- 84 institutional investors held TriSalus Life Sciences (TLSI) as of Q1 2026, up from 67 in Q4 2025.
- Funds reported $83.3M of TriSalus Life Sciences stock for Q1 2026, up 4.4% quarter-over-quarter.
- 29 funds opened new TriSalus Life Sciences positions in Q1 2026 and 10 closed out, a net change of +19 holders.
- The largest TriSalus Life Sciences buyer in Q1 2026 was First Light Asset Management, an estimated $24.8M added.
- The largest TriSalus Life Sciences seller in Q1 2026 was Wealthcare Advisory Partners, an estimated $4.49M sold.
Based on aggregated 13F filings for Q1 2026.